These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8107309)

  • 1. Pressor effect of recombinant human erythropoietin: results of home blood pressure measurements in hemodialysis patients.
    Imai Y; Fujikura Y; Minami N; Munakata M; Hashimoto J; Sakuma H; Watanabe N; Nishiyama A; Misawa S; Sekino H
    Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):51-6. PubMed ID: 8107309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressor effect of recombinant human erythropoietin: results of ambulatory blood pressure monitoring and home blood pressure measurements.
    Imai Y; Sekino H; Fujikura Y; Munakata M; Minami N; Hashimoto J; Sakuma H; Watanabe N; Misawa S; Nishiyama A
    Clin Exp Hypertens; 1995 Apr; 17(3):485-506. PubMed ID: 7613524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
    Yamakado M; Umezu M; Nagano M; Tagawa H
    Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration].
    Stutz B; Rhyner K; Vögtli J; Binswanger U
    Schweiz Med Wochenschr; 1987 Sep; 117(38):1397-402. PubMed ID: 3672079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO).
    Roger SD; Baker LR; Raine AE
    Clin Nephrol; 1993 Feb; 39(2):103-10. PubMed ID: 8448912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of renal anemia with recombinant human erythropoietin].
    Burghard R; Gordjani N; Leititis JU
    Monatsschr Kinderheilkd; 1989 Mar; 137(3):174-7. PubMed ID: 2716749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of home pressure monitoring in the treatment hypertension in the practice of general medicine].
    Widimský J; Balazovjech I; Lánská V
    Vnitr Lek; 1999 Oct; 45(10):569-77. PubMed ID: 10951863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in diurnal blood pressure variation and red cell and plasma volumes in patients with renal failure who develop erythropoietin-induced hypertension.
    Jones MA; Kingswood JC; Dallyn PE; Andrew M; Cheetham A; Burwood R; Sharpstone P
    Clin Nephrol; 1995 Sep; 44(3):193-200. PubMed ID: 8556836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Home blood pressure self-measurement in children and adolescents with renal replacement therapy].
    Bald M; Böhm W; Feldhoff C; Bonzel KE
    Klin Padiatr; 2001; 213(1):21-5. PubMed ID: 11225470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of recombinant human erythropoietin administration on cardiovascular system in patient with chronic renal failure: an analysis of the blood pressure upward].
    Satoh K; Ikeda Y; Kurokawa S; Kamata K; Masuda T; Kikawada R; Marumo F
    Kokyu To Junkan; 1989 Mar; 37(3):313-9. PubMed ID: 2734509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GHRH) stimulation in hemodialysis patients.
    Cremagnani L; Cantalamessa L; Orsatti A; Vigna L; Vallino F; Buccianti G
    Clin Nephrol; 1993 May; 39(5):282-6. PubMed ID: 8513607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
    Eschbach JW; Egrie JC; Downing MR; Browne JK; Adamson JW
    N Engl J Med; 1987 Jan; 316(2):73-8. PubMed ID: 3537801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
    Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J
    Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home blood pressure recording in mild hypertension: value of distinguishing sustained from clinic hypertension and effect on diagnosis and treatment. Bath Health District Hypertension Study Group.
    Hall CL; Higgs CM; Notarianni L
    J Hum Hypertens; 1990 Oct; 4(5):501-7. PubMed ID: 2283640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin].
    Sivak L; Scuteri RM; Cavalli NH; Gotlieb D; López Blanco OA
    Medicina (B Aires); 1992; 52(6):516-22. PubMed ID: 1340900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
    Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M
    Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
    Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T
    Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rate of increase in hematocrit, humoral vasoactive substances and blood pressure changes in hemodialysis patients treated with recombinant human erythropoietin or blood transfusion.
    Ono K; Hisasue Y
    Clin Nephrol; 1992 Jan; 37(1):23-7. PubMed ID: 1531789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.